Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jun;6(2):155-157.
doi: 10.1136/svn-2021-000885. Epub 2021 Mar 16.

Residual recurrence risk of ischaemic cerebrovascular events: concept, classification and implications

Yongjun Wang  1   2
Affiliations
Editorial

Residual recurrence risk of ischaemic cerebrovascular events: concept, classification and implications

Yongjun Wang. Stroke Vasc Neurol. 2021 Jun.
No abstract available

Keywords: stroke.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Classifications of stroke residual risk.
Figure 2
Figure 2
Multiple omics for undetermined mechanism of stroke residual risk.
See this image and copyright information in PMC

References

    1. Ji R, Liu G, Shen H, et al. . Persistence of secondary prevention medications after acute ischemic stroke or transient ischemic attack in Chinese population: data from China national stroke Registry. Neurol Res 2013;35:29–36. 10.1179/1743132812Y.0000000107 - DOI - PubMed
    1. Patel KV, Pandey A, de Lemos JA. Conceptual framework for addressing residual atherosclerotic cardiovascular disease risk in the era of precision medicine. Circulation 2018;137:2551–3. 10.1161/CIRCULATIONAHA.118.035289 - DOI - PubMed
    1. Ridker PM. Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin. Eur Heart J 2016;37:1720–2. 10.1093/eurheartj/ehw024 - DOI - PubMed
    1. Li J, Zhao X, Meng X. High-Sensitive C-reactive protein predicts recurrent stroke and poor functional outcome: subanalysis of the clopidogrel in high-risk patients with acute Nondisabling cerebrovascular events trial. Stroke 2016;47:2025–30. 10.1161/STROKEAHA.116.012901 - DOI - PubMed
    1. Bushnell CD, Olson DM, Zhao X, et al. . Secondary preventive medication persistence and adherence 1 year after stroke. Neurology 2011;77:1182–90. 10.1212/WNL.0b013e31822f0423 - DOI - PMC - PubMed

Publication types

LinkOut - more resources